Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 7 | 3 | 0 | 0 | 0 |
| Cost of Goods | 5 | 2 | 0 | N/A | N/A |
| Gross Profit | 2 | 2 | 0 | N/A | N/A |
| Operating Expenses | 210 | 69 | 124 | 37 | 289 |
| Operating Income | -203 | -66 | -122 | -128 | -289 |
| Interest Expense | 28 | 18 | 46 | 24 | 21 |
| Other Income | -120 | -46 | -32 | -114 | -604 |
| Pre-tax Income | -350 | -131 | -200 | -266 | -913 |
| Net Income Continuous | -350 | -131 | -200 | -266 | -913 |
| Net Income Discontinuous | N/A | N/A | N/A | -29 | 5 |
| Net Income | $-350 | $-131 | $-200 | $-266 | $-908 |
| EPS Basic Total Ops | -80.00 | -280.00 | -100.00 | -1,380.00 | -40.00 |
| EPS Basic Continuous Ops | -80.00 | -60.00 | -100.00 | -1,368.72 | -40.00 |
| EPS Basic Discontinuous Ops | 0.00 | -240.00 | 0.00 | N/A | 0.00 |
| EPS Diluted Total Ops | -80.00 | -280.00 | -100.00 | -1,380.00 | -40.00 |
| EPS Diluted Continuous Ops | -80.00 | -60.00 | -100.00 | -1,368.72 | -40.00 |
| EPS Diluted Discontinuous Ops | 0.00 | -240.00 | 0.00 | N/A | 0.00 |
| EBITDA(a) | $-199 | $-76 | $-107 | $-31 | $-253 |